Effects of abaloparatide on bone mineral density and risk of fracture in postmenopausal women aged 80 years or older with osteoporosis. (2018)
Attributed to:
Lifecourse Determinants of Bone and Joint Disease
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1097/gme.0000000000001080
PubMed Identifier: 29462094
Publication URI: http://europepmc.org/abstract/MED/29462094
Type: Journal Article/Review
Volume: 25
Parent Publication: Menopause (New York, N.Y.)
Issue: 7
ISSN: 1072-3714